BioLife Solutions, Inc. (BLFS) is a leading developer and supplier of biopreservation tools and services that are critical for the preservation, storage, and transportation of cells, tissues, and organs used in the biopharmaceutical industry.
The company’s innovative products, including CryoStor and HypoThermosol, are designed to optimize the viability and function of biological materials during the manufacturing, storage, and distribution processes. BioLife’s solutions are widely used in cell and gene therapy, regenerative medicine, and biobanking, making them an essential part of the supply chain for emerging medical technologies.
The company also offers cloud-connected freezer systems and thawing devices that ensure the integrity of biologic materials throughout their lifecycle. Key drivers of growth for BioLife Solutions include the increasing demand for cell and gene therapies, the expansion of biobanking services, and the company’s strategic acquisitions that broaden its product offerings.
With a strong focus on innovation and customer support, BioLife Solutions is well-positioned to continue leading in the biopreservation market and to play a crucial role in the advancement of life-saving therapies.
